These limitations highlight the need for future studies with larger clinical cohorts, tissue-specific functional experiments, and animal models to fully validate and expand the role of the CXCL1–ERS–TXNDC5 axis in atrial remodeling and AF pathogenesis. Here, CXCL1 is linked to atrial fibrillation.